Implantation of a heart rate modulation device in the treatment of chronic heart failure with reduced ejection fraction and atrial fibrillation

Natalia S. Zobova , Jamilya A. Omarova , Kira L. Seydalieva , Raiz M. Yarakhmedov

For citation:

Abstract

Chronic heart failure (CHF) is one of the actively developed problems of modern cardiology. The presence of atrial fibrillation (AF) leads to an increased likelihood of death. For patients with CHF resistant to optimal drug therapy on the background of AF, the implantation of а heart rate modulation device is one of the promising treatment methods that increase life expectancy and quality of life. New generations of devices have appeared that allow implanting 2 ventricular electrodes without atrial detection. However, this treatment method requires further research to assess safety and complication rates, including in the presence of AF. The article presents a clinical case of CHF of ischemic origin with reduced ejection fraction and AF with the implantation of a device for heart rate modulation, and an assessment of its effectiveness is given.
Keywords: chronic heart failure with reduced ejection fraction, atrial fibrillation, heart rate modulation.

References

1. Жиров И.В., Романова Н.В., Терещенко С.Н. и др. Эпидемиология и особенности терапии хронической сердечной недостаточности в сочетании с фибрилляцией предсердий. Кардиология. 2015;55(3): 91-6.

Zhirov I.V., Romanova N.V., Tereshchenko S.N. et.al. Epidemiology and treatment features of chronic heart failure in combination with atrial fibrillation. Cardiology. 2015;55(3):91-6 (in Russian).

2. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016;(8):7-13. DOI: 10.15829/1560-4071-2016-8-7-13

Fomin I.V. Chronic heart failure in the Russian Federation: what we know today and what we should do. Russian Journal of Cardiology. 2016;(8):7-13. DOI: 10.15829/1560-4071-2016-8-7-13 (in Russian)

3. Zafrir B, Lund LH, Laroche C et al. ESC-HFA HF Long-Term Registry Investigators et al. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry. Eur Heart J 2018;39(48):4277-84. DOI: 10.1093/eurheartj/ehy626

4. Ziff OJ, Carter PR, McGowan J, et al The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: insights from the United Kingdom ACALM registry. Int J Cardiol 2018;(252):117121. DOI: 10.1016/j.ijcard.2017.06.033

5. Ревишвили А.Ш., Артюхина Е.А., Амирасланов А.Ю. и др. Первый опыт лечения пациентов с хронической сердечной недостаточностью методом имплантации устройств, модулирующих сокращения сердца. Вестник аритмологии. 2017;(90):12-8.

Revishvili A.Sh., Artyukhina E.A., Amiraslanov A.Yu. et al. The first experience of treating patients with chronic heart failure by implanting devices that modulate heart contractions. Bulletin of Arrhythmology. 2017;(90):12-8 (in Russian).

6. Ускач Т.М., Сапельников О.В., Сафиуллина А.А. и т.д. Имплантация модулятора сердечной сократимости при хронической сердечной недостаточность и фибрилляции предсердий, результаты 6-месячного наблюдения ста пациентов. Вестник трансплантологии и искусственных органов. 2021;23(1):30-7.

Uskach T.M., Sapelnikov O.V., Safiullina A.A. et al. Implantation of a modulator of cardiac contractility in chronic heart failure and atrial fibrillation, results of a 6-month follow-up of one hundred patients. Bulletin of Transplantology and Artificial Organs. 2021;23(1):30-7 (in Russian).

7. Шарапова Ю.Ш., Сафиуллина А.А., Ускач Т.М. и др. Клинические эффекты модуляции сердечной сократимости при различных формах фибрилляции предсердий у пациентов с хронической сердечной недостаточностью. Кардиологический вестник. 2022;17(1): 42-51.

Sharapova Yu.Sh., Safiullina A.A., Uskach T.M. et al. Clinical effects of modulation of cardiac contractility in various forms of atrial fibrillation in patients with chronic heart failure. Cardiological Bulletin. 2022;17(1):42-51 (in Russian).

8. Поляков Д.С., Фомин И.В., Беленков Ю.Н. и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021;61(4):4-14. DOI: 10.18087/cardio.2021.4.n1628

Polyakov D.S., Fomin I.V., Belenkov Yu.N. et al. Chronic heart failure in the Russian Federation: what has changed in 20 years of observation? The results of the EPOCH-CHF study. Cardiology. 2021;61(4):4-14. DOI: 10.18087/cardio.2021.4.n1628 (in Russian).

For citation:Zobova N.S., Omarova J.A., Seydalieva K.L., Yarakhmedov R.M. Implantation of a heart rate modulation device in the treatment of chronic heart failure with reduced ejection fraction and atrial fibrillation. Clinical review for general practice. 2025; 6 (11): 91–94 (In Russ.). DOI: 10.47407/kr2025.6.11.00726

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice